Literature DB >> 9328112

Antibodies to Jo-1 and Ro-52: why do they go together?

P J Venables.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9328112      PMCID： PMC1904762          DOI： 10.1046/j.1365-2249.1997.4761369.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  5 in total

1.  [Correlation study on anti-Ro52 antibodies frequently co-occur with other myositis-specific and myositis-associated autoantibodies].

Authors:  Y M Zheng; H J Hao; Y L Liu; J Guo; Y W Zhao; W Zhang; Y Yuan
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-18

Review 2.  A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity.

Authors:  Adrian Y S Lee
Journal:  Rheumatol Int       Date:  2017-04-17       Impact factor: 2.631

3.  Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis.

Authors:  M Fathi; M Dastmalchi; E Rasmussen; I E Lundberg; G Tornling
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

4.  [New aspects on the pathogenesis of myositis].

Authors:  B Stuhlmüller; E Feist; T Häupl; G-R Burmester; N Pipitone
Journal:  Z Rheumatol       Date:  2013-04       Impact factor: 1.372

Review 5.  Anti-Ro52 Autoantibody Is Common in Systemic Autoimmune Rheumatic Diseases and Correlating with Worse Outcome when Associated with interstitial lung disease in Systemic Sclerosis and Autoimmune Myositis.

Authors:  Edward K L Chan
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-18       Impact factor: 10.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.